Antimicrobial prophylaxis and the prevention of surgical site infection in cardiac surgery: an analysis of 21 007 patients in Switzerland†.

Sommerstein, Rami; Atkinson, Andrew; Kuster, Stefan P; Thurneysen, Maurus; Genoni, Michele; Troillet, Nicolas; Marschall, Jonas; Widmer, Andreas F (2019). Antimicrobial prophylaxis and the prevention of surgical site infection in cardiac surgery: an analysis of 21 007 patients in Switzerland†. European journal of cardio-thoracic surgery, 56(4), pp. 800-806. Oxford University Press 10.1093/ejcts/ezz039

[img] Text
R Sommerstein et al.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (475kB) | Request a copy

OBJECTIVES Our goal was to determine the optimal timing and choice of surgical antimicrobial prophylaxis (SAP) in patients having cardiac surgery. METHODS The setting was the Swiss surgical site infection (SSI) national surveillance system with a follow-up rate of >94%. Participants were patients from 14 hospitals who had cardiac surgery from 2009 to 2017 with clean wounds, SAP with cefuroxime, cefazolin or a vancomycin/cefuroxime combination and timing of SAP within 120 min before the incision. Exposures were SAP timing and agents; the main outcome was the incidence of SSI. We fitted generalized additive and mixed-effects generalized linear models to describe effects predicting SSIs. RESULTS A total of 21 007 patients were enrolled with an SSI incidence of 5.5%. Administration of SAP within 30 min before the incision was significantly associated with decreased deep/organ space SSI [adjusted odds ratio (OR) 0.73, 95% confidence interval (CI) 0.54-0.98; P = 0.035] compared to administration of SAP 60-120 min before the incision. Cefazolin (adjusted OR 0.64, 95% CI 0.49-0.84; P = 0.001) but not vancomycin/cefuroxime combination (adjusted OR 1.05, 95% CI 0.82-1.34; P = 0.689) was significantly associated with a lower risk of overall SSI compared to cefuroxime alone. Nevertheless, there were no statistically significant differences between the SAP agents and the risk of deep/organ space SSI. CONCLUSIONS The results from this large prospective study provide substantial arguments that administration of SAP close to the time of the incision is more effective than earlier administration before cardiac surgery, making compliance with SAP administration easier. The choice of SAP appears to play a significant role in the prevention of all SSIs, even after adjusting for confounding variables.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Sommerstein, Rami; Atkinson, Andrew and Marschall, Jonas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1873-734X

Publisher:

Oxford University Press

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

23 Apr 2019 11:03

Last Modified:

31 Oct 2019 16:51

Publisher DOI:

10.1093/ejcts/ezz039

PubMed ID:

30796448

Uncontrolled Keywords:

Cardiac surgery Infection control Modelling Prevention Surgical antimicrobial prophylaxis Surgical site infection

BORIS DOI:

10.7892/boris.127403

URI:

https://boris.unibe.ch/id/eprint/127403

Actions (login required)

Edit item Edit item
Provide Feedback